Peritoneal Carcinomatosis Extent Evaluation: Radiologic, Laparoscopic and Pathologic.

Imaging Evaluation of Peritoneal Carcinomatosis Extent

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT03798132

Enrollment

Registered

2019-01-09

Start date

2019-01-01

Completion date

2020-12-31

Last updated

2019-01-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Peritoneal Carcinomatosis

Keywords

Ovarian Neoplasms, Laparoscopy, Cytoreduction Surgical Procedures.

Brief summary

pathologically proved ovarian cancer patients that underwent contrast enhanced abdomino-pelvic CT and diagnostic laparoscopy before cytoreductive surgery (CRS) will be included in the study. Calculation of PCI (peritoneal cancer index) using Sugarbaker's method, peritoneal carcinomatosis extent will be categorized into low, moderate and large. Agreement in general and in each category between CT, laparoscopy, surgery and pathology will be assessed using kappa agreement.

Detailed description

we will search medical records of primary ovarian cancer patients underwent CT abdomen, laparoscopy followed by cytoreductive surgery to calculate peritoneal carcinomatosis extent by each modality. Regional PCI was calculated in each of the 13 anatomical abdominopelvic regions, then total PCI by summation of the lesion size score, it ranged from 0 to 39. Categorization of peritoneal carcinomatosis was classified into 3 categories low if PCI \< 10, moderate if 10-20, and large if \>20.

Interventions

DIAGNOSTIC_TESTlaparoscopy

evaluation of peritoneal carcinomatosis by laparoscopy

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

FEMALE

Age

18 Years to 100 Years

Healthy volunteers

Inclusion criteria

pathologically proved ovarian cancer patients underwent contrast enhanced abdominopelvic CT and diagnostic laparoscopy before cytoreductive surgery -

Exclusion criteria

recurrent ovarian cancer \-

Design outcomes

Primary

Measure	Time frame	Description
peritoneal carcinomatosis	one year	Agreement in general and in each category between CT, laparoscopy, surgery and pathology was assessed using kappa agreement.

Secondary

Measure	Time frame	Description
surgical decision making.	one year	correlation of peritoneal carcinomatosis categorization with surgical decision

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026